Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs-Reference-Cited by-同舟云学术

Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs

Published:2018-12 Issue: Volume:53 Page:110-124
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Buzdin Anton,Sorokin Maxim,Garazha Andrew,Sekacheva Marina,Kim Ella,Zhukov Nikolay^ORCID,Wang Ye,Li Xinmin,Kar Souvik^ORCID,Hartmann Christian,Samii Amir,Giese Alf,Borisov Nicolas^ORCID

Funder

Russian Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research

Reference155 articles.

1. Testicular cancer: a reflection on 50 years of discovery;Hanna;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2014

2. Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy;Ahles;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2005

3. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients;Kayl;Curr. Opin. Obstet. Gynecol.,2006

4. Targeted therapy in the treatment of solid tumors: practice contradicts theory;Zhukov;Biochem. Biokhimii͡a,2008

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Blood Serum Antagonizes Effects of EGFR/HER2-Targeted Drug Lapatinib on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Биохимия;2024-09-14

2. Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (TERT) gene expression status;Frontiers in Genetics;2024-05-27

3. Potential Application Prospects of Biomolecule-Modified Two-Dimensional Chiral Nanomaterials in Biomedicine;ACS Biomaterials Science & Engineering;2024-03-20

4. Human Blood Serum Counteracts EGFR/HER2-Targeted Drug Lapatinib Impact on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Biochemistry (Moscow);2024-03

5. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme;BMC Cancer;2024-01-02